Coming Off Venlafaxine (Efexor) — Safe Tapering Support UK

Venlafaxine — the basics

Venlafaxine (often known as Efexor) is a serotonin–noradrenaline reuptake inhibitor (SNRI). In plain terms, it changes how two chemical messengers in the nervous system are recycled. It is prescribed for depression and several anxiety-related conditions. Some people take immediate-release (IR) tablets; others take extended-release (XL/XR) capsules.

An SNRI Can affect both serotonin (mood, sleep, gut, senses) and noradrenaline (alertness, drive, “rev”) — a sketch, not a map of the brain

Cleared relatively quickly Levels can dip sooner than with a longer-acting antidepressant such as fluoxetine — one reason a late dose can be noticeable

IR and XL/XR How the product is designed to release changes how steadily it is delivered, and what strengths exist on the shelf

Can venlafaxine be hard to stop?

Yes — for a significant proportion of people, especially those who have taken it for a long time. People are often advised, in general terms, to reduce antidepressants over a few weeks. For long-term venlafaxine that pace is too fast for many.

Three patterns come up again and again with this medicine.

A late dose Many people notice a change if a dose is later than usual. “I feel it if I’m late” is a recognised pattern for this medicine — not proof of a particular diagnosis. Because venlafaxine is cleared relatively quickly, a dip can be felt in the body, the senses, mood or sleep before anyone would expect the original illness to have returned.

The pace A reduction over a few weeks can still be too steep, particularly as the dose becomes lower. A hard attempt often reflects pace — not that you “can’t come off.”

The product IR or XL, tablet or capsule, brand or generic: formulation changes how steadily the medicine is delivered and what a pharmacy can actually supply. A conversation about feeling unwell after a brand switch or a late XL capsule often starts with “what is on the box?”

People describe a wide range of experiences when a dose is late, reduced or stopped. Not everyone notices these. They are a map of language, not a diagnostic checklist.

Body Nausea, stomach upset, sweating, flu-like feelings, fatigue, headaches.

Balance and senses Dizziness or unsteadiness, electric-shock feelings (“brain zaps”), tingling, tinnitus, visual changes. New, severe or one-sided symptoms should be assessed as they would be at any other time.

Sleep Insomnia, vivid dreams, nightmares.

Mood and thinking Anxiety, irritability, tearfulness, agitation, concentration difficulty, mental fog. Mood and thinking changes after a reduction can be withdrawal, recurrence, or both.

The nervous system adapts to the medicine being there — then has to readjust when the amount changes.

Why smaller reductions may be needed at lower doses

People often expect coming down from a higher dose to be the hard part, and the last tablets or capsules to be easy. With venlafaxine, some people notice the opposite: later, smaller-looking amounts feel more noticeable.

NICE guidance on stopping antidepressants describes gradual, stepwise reductions that are proportionate to the existing dose, with the size and timing adjusted according to the individual and how they respond.

Proportional tapering means reducing by a proportion of the current dose, rather than taking the same number of milligrams away each time. The reductions therefore become smaller as the dose itself becomes lower.

The Royal College of Psychiatrists also describes hyperbolic tapering, which takes account of the fact that the relationship between antidepressant dose and its effects on the brain is not linear. For some people, this may mean that particularly small reductions are needed towards the lower end of the dose range.

This diagram illustrates a general principle rather than a personal tapering schedule. The appropriate size, timing and method of dose reductions varies between individuals and should be discussed with the prescribing clinician.

XR, tablets and what is on the box

Formulation is not jargon for its own sake. It changes how steadily venlafaxine is delivered, what strengths exist on the shelf, and what a pharmacy can actually supply. Products differ. This is a map of words you may hear, not a list of what you should be on.

IR Released relatively quickly. Often tablets. May be taken more than once a day if that is how it was prescribed. Some people notice peaks and dips more readily.

XL / XR Designed to release more slowly, often once daily. Commonly capsules in the UK. Smoother by design, though many people still notice a late XL dose. Capsules are not interchangeable. Brands, coatings and labelled strengths can all differ — even if both boxes say “venlafaxine XL.”

IR and XL, simplified — not a personal blood-level chart

Some people notice IR peaks and dips more; XL is designed to flatten that. Not an instruction to switch. How a particular product is used is a prescriber and pharmacist matter.

Labelled strengths

In the UK, a commonly available tablet strength is 37.5 mg. For some people, that still feels like a large step when they are already on a lower prescribed dose.

Liquids and specials

Where smaller steps are needed, a different strength, a liquid, or a specially prepared product may sometimes be used — under the guidance of a prescriber or pharmacist, not by improvising from a webpage.

Why “bead counting” comes up online

Some extended-release capsules contain many small coated units. People look for a language for amounts smaller than the next labelled strength. This page does not teach a method, give numbers, or tell you to open a capsule. Another person’s box cannot be copied onto yours. If the labelled strengths feel large at the dose you are on, that is a conversation with a pharmacist or prescriber — starting with what is actually on your packaging.

Key points about stopping venlafaxine

Do not stop venlafaxine abruptly after prolonged use
Smaller reductions are often needed at lower doses, and labelled strengths may not always allow this
If symptoms are significant after a reduction, discuss the next step with the prescribing clinician before reducing further

Will my depression come back if I stop?

This is one of the highest-value questions people bring — and it cannot be answered by a webpage. The three ideas below can overlap in the same week.

More like withdrawal Changes that sit in relation to a missed dose, a reduction, a product switch or stopping. Physical or sensory experiences may feel unfamiliar compared with the original illness.

More like recurrence A return of the problem venlafaxine was prescribed for — more like your earlier pattern of depression, anxiety or panic.

Something else Sleep loss, physical illness, other medicines, alcohol, life events, another diagnosis. Lists are not exhaustive.

Our explainer goes into more detail: Withdrawal or relapse — understanding the difference.

What if I have tried to stop before and found it very difficult?

This is one of the most common reasons people look for better information about venlafaxine. A hard attempt is information — not a moral result, and not a sign that the medicine is needed permanently.

Too fast People are often advised to reduce antidepressants over a few weeks. For long-term venlafaxine that pace is too steep for many, especially at the lower doses. A timeline of what changed, and when you first noticed something different, is often more useful to a clinician than a single story of “it was awful.”

Misread Dizziness, zaps, anxiety or a sudden dip in mood are treated as relapse, so the dose is put back up — when a slower step, or a pause, may have been the clinical question.

Formulation The next labelled tablet or capsule can still be a large step for the nervous system. If a previous attempt stalled here, it may have been a limitation of the product rather than a sign that stopping is impossible.

A phrase you may hear: fluoxetine bridging

Fluoxetine stays in the body much longer than venlafaxine. Because of that, some clinicians, in some situations, discuss using fluoxetine as part of a planned, supervised change when stopping venlafaxine has been particularly difficult. Details vary. Evidence and practice are not uniform. Whether it is relevant is an individual medical decision — not a kit from this page.

You may also want What is hyperbolic tapering? and What makes deprescribing safe.

Stopping venlafaxine is not about willpower, and a difficult previous attempt is not a verdict.

With the right pace, a way to interpret what happens after each change, and a clinician who can read the picture, most people can reduce carefully — and stay well throughout.

Coming off venlafaxine — what to expect and how to do it safely